Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement (CSI-TAVR)

University of Ulm

Status: Completed

Conditions: Aortic Valve Stenosis

Treatments: Device: CE certified transcatheter ( aortic valve replacement)

Study type: Interventional

Funder types: Other

Identifiers

NCT02162069

CSI TAVR 1.0

Details and patient eligibility

About

To evaluate the long-term results after transcatheter aortic valve replacement

Full description

Patients with transcatheter aortic valve replacement are followed for 5 years to demonstrate efficacy and safety.

Enrollment: 843 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• aortic valve stenosis
• transcatheter aortic valve replacement

Exclusion criteria

• no written informed consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

843 participants in 1 patient group

transcatheter aortic valve replacement

Experimental group

Description:

Patients receive transcatheter aortic valve replacement.

Treatment:

Device: CE certified transcatheter ( aortic valve replacement)